R E Ferner
Impact in
- Toxicology top 0.1%
- Pharmacovigilance and Adverse Drug Reactions
- Geriatrics and Gerontology top 0.5%
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Toxicology 44
- Pharmacovigilance and Adverse Drug Reactions 37
-
- Pharmaceutical studies and practices 22
- Co-authors
- Jeffrey K Aronson (38 shared papers)Sarah McDowell (17 shared papers)Jamie J. Coleman (22 shared papers)Anthony Cox (18 shared papers)Sally Bradberry (3 shared papers)J. Mark Wilkinson (1 shared paper)H. A. W. Neil (1 shared paper)D. Nicholas Bateman (8 shared papers)
- Journals
- British Journal of Clinical Pharmacology (44 papers)Drug Safety (28 papers)BMJ (9 papers)Journal of the Royal Society of Medicine (7 papers)Clinical Toxicology (6 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
R E Ferner
219 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 188
- Toxicology 673
- Geriatrics and Gerontology 514
- Emergency Medical Services 474
- Family Practice 86
- Pharmacology 396
Countries citing papers authored by R E Ferner
This map shows the geographic impact of R E Ferner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R E Ferner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R E Ferner more than expected).
Fields of papers citing papers by R E Ferner
This network shows the impact of papers produced by R E Ferner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R E Ferner. The network helps show where R E Ferner may publish in the future.
Co-authors
The 25 scholars most cited alongside R E Ferner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 230 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 279 | |
| 2 | 1999 | 258 | |
| 3 | 2005 | 219 | |
| 4 | 2014 | 195 | |
| 5 | 2006 | 192 | |
| 6 | 2006 | 190 | |
| 7 | 1994 | 171 | |
| 8 | 2008 | 128 | |
| 9 | 1988 | 113 | |
| 10 | 2011 | 107 | |
| 11 | 1989 | 104 | |
| 12 | 2009 | 100 | |
| 13 | 2010 | 96 | |
| 14 | 2020 | 96 | |
| 15 | 2013 | 78 | |
| 16 | 1987 | 75 | |
| 17 | 2006 | 74 | |
| 18 | 1983 | 71 | |
| 19 | 2019 | 68 | |
| 20 | 1987 | 66 |
About R E Ferner
R E Ferner is a scholar working on Toxicology, Pediatrics, Perinatology and Child Health, Pharmacology, Pharmacology and Geriatrics and Gerontology, having authored 230 papers that have together received 5.3k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (37 papers), Pharmaceutical studies and practices (22 papers), Pharmaceutical Practices and Patient Outcomes (20 papers), Poisoning and overdose treatments (19 papers), Patient Safety and Medication Errors (16 papers), Pharmaceutical Economics and Policy (16 papers), Drug-Induced Adverse Reactions (14 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). The work is most often cited by research in Toxicology (673 citations), Geriatrics and Gerontology (514 citations), Emergency Medical Services (474 citations), Family Practice (86 citations) and Pharmacology (396 citations). R E Ferner has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Jeffrey K Aronson, Sarah McDowell, Jamie J. Coleman, Anthony Cox, Sally Bradberry, J. Mark Wilkinson, H. A. W. Neil, D. Nicholas Bateman, J K Aronson and M. D. Rawlins. Their work appears in journals such as British Journal of Clinical Pharmacology, Drug Safety, BMJ, Journal of the Royal Society of Medicine and Clinical Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.